⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11001835 | 0.97 | — | — | |
| Trifluoroacetic Acid SCHEMBL30409309 | 0.84 | LMNA (0.37) | — | |
| Trifluoroacetic Acid SCHEMBL30408756 | 0.84 | LMNA (0.37) | — | |
| SCHEMBL17447544 | 0.83 | PSMB5 (0.53) | — | |
| SCHEMBL2785652 | 0.82 | MCL1 (0.40) | — | |
| SCHEMBL13627720 | 0.80 | — | — | |
| SCHEMBL13451612 | 0.80 | — | — | |
| SCHEMBL5670925 | 0.80 | — | — | |
| SCHEMBL15145452 | 0.79 | MMP2 (0.40) | — | |
| SCHEMBL14532758 | 0.79 | MMP2 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 520 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109790440-B | Tire puncture repair material and tire puncture repair kit | 横滨橡胶株式会社 | 2022-04-08 | — | — | CN | claimed |
| EP-2661436-B1 | NOVEL SULFAMIDE PIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF | LEO PHARMA AS (DK) | 2016-04-13 | — | — | EP | claimed |
| EP-1682104-A2 | MIGRAINE TREATMENTS INCLUDING ISOVALERAMIDE COMPOUNDS AND SEROTONIN AGONISTS | NPS PHARMACEUTICALS, INC. (US) | 2006-07-26 | — | — | EP | claimed |
| WO-2005046659-A2 | MIGRAINE TREATMENTS INCLUDING ISOVALERAMIDE COMPOUNDS AND SEROTONIN AGONISTS | NPS PHARMACEUTICALS, INC. (US) | 2005-05-26 | — | — | WO | claimed |
| EP-1064257-A1 | ANTI-TUMOUR AGENTS | AstraZeneca AB (SE) | 2001-01-03 | — | — | EP | claimed |
| WO-1999048860-A1 | ANTI-TUMOUR AGENTS | ASTRAZENECA AB (SE) | 1999-09-30 | — | — | WO | claimed |
| CN-1028227-C | Pharmacologically active 1,5-diarly-3-substituted-pyrazoles and method for synthesizing the same | ORTHO PHARMA CORP (US) | 1995-04-19 | — | — | CN | claimed |
| US-12410208-B2 | (2-acetamidyl)thio-beta-D-galactopyranoside derivatives | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-09-09 | — | — | US | disclosed |
| EP-4601701-A1 | ANTIBODY-DRUG CONJUGATE BINDING TO HUMAN PTK7 AND METHOD FOR PREPARATION AND USE THEREOF | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) | 2025-08-20 | — | — | EP | disclosed |
| EP-4596550-A1 | COMPOUND USABLE IN CONJUGATION REACTION AND CONJUGATE THEREOF | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) | 2025-08-06 | — | — | EP | disclosed |
| US-12357701-B2 | Anti-HER2 biparatopic antibody-drug conjugates and methods of use | ZYMEWORKS BC INC. (CA) | 2025-07-15 | — | — | US | disclosed |
| CN-119997983-A | Antibody drug conjugate, preparation method and application thereof | 四川科伦博泰生物医药股份有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-114025795-B | Methods of treating biliary tract cancer using bispecific antigen binding constructs that target HER2 | 酵活英属哥伦比亚有限公司 | 2025-04-29 | — | — | CN | disclosed |
| US-5594003-A | HYPOTENSIVE AGENTS | DR. KARL THOMAE GMBH (DE) | 1997-01-14 | — | — | US | disclosed |
| US-5591762-A | HYPOTENSIVE AGENTS | DR. KARL THOMAE GMBH (DE) | 1997-01-07 | — | — | US | disclosed |
| EP-0546409-A1 | Method for the preparation of tetrahydropyrancarboxylic esters | BASF Aktiengesellschaft (DE) | 1993-06-16 | — | — | EP | disclosed |
| EP-0430738-A2 | Use of an imidazopyridine for the manufacture of anesthetic medicaments | SYNTHELABO (FR) | 1991-06-05 | — | — | EP | disclosed |
| US-4880930-A | ANXIOLYTIC AGENTS | BRISTOL-MYERS COMPANY, A CORP. OF DE. | 1989-11-14 | — | — | US | disclosed |
| EP-0318933-A2 | Psychotropic acyclic amide derivatives, a process for preparing them and pharmaceutical compositions | Bristol-Myers Squibb Company (US) | 1989-06-07 | — | — | EP | disclosed |
| EP-0013044-A1 | L-aspartyl amide derivatives and their use as sweetening agents | THE PROCTER & GAMBLE COMPANY (US) | 1980-07-09 | — | — | EP | disclosed |